The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?

Publisher： Karger

E-ISSN： 1423-0143|36|1|335-343

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.36, Iss.1, 2012-12, pp. : 335-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-10 ,pp. : 278-282

Karger

Access to resources Recommend Favorite

Dual Renin-Angiotensin System Blockade for Nephroprotection: Still under Scrutiny

By  

Nephron, Vol. 129, Iss. 1, 2014-12 ,pp. : 39-41

Karger

Access to resources Recommend Favorite

Effects of Mono- and Dual Blockade of the Renin-Angiotensin System on Markers of Cardiovascular Status in Hypertensive Patients with Mild and Moderate Renal Failure

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 3, 2011-03 ,pp. : 150-157

Karger

Access to resources Recommend Favorite

Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study

By  

American Journal of Nephrology, Vol. 43, Iss. 6, 2016-05 ,pp. : 431-440

Karger

Access to resources Recommend Favorite

Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 4, 2005-12 ,pp. : 230-242

Karger

Access to resources Recommend Favorite